Frank Litvak
Corporate Officer/Principal bei University of California, Los Angeles
Profil
Frank Litvak is the founder of Progressive Angioplasty Systems, Inc. founded in 1989.
He is currently a Professor at the University of California, Los Angeles since 2000 and a Member at Calmedica LLC since 1996.
Dr. Litvak's former positions include Chairman & Chief Executive Officer at Conor Medsystems LLC from 2002 to 2007, Chairman at Savacor, Inc. in 2005, and Co-Director-Cardiovascular Intervention Center at Cedars-Sinai Medical Center from 1986 to 2000.
He was also a Director at Genalyte, Inc. Dr. Litvak holds a doctorate degree from McGill University.
Aktive Positionen von Frank Litvak
Unternehmen | Position | Beginn |
---|---|---|
University of California, Los Angeles | Corporate Officer/Principal | 01.01.2000 |
Calmedica LLC | Corporate Officer/Principal | 01.01.1996 |
Ehemalige bekannte Positionen von Frank Litvak
Unternehmen | Position | Ende |
---|---|---|
Conor Medsystems LLC
Conor Medsystems LLC Medical SpecialtiesHealth Technology Conor Medsystems LLC develops vascular drug delivery technologies. Its products include controlled vascular drug delivery technologies and novel stent that are used in the treatment of coronary artery disease and delivery of a broad spectrum of therapeutic agents. The company was founded by John F. Shanley in 1999 and is headquartered in Menlo Park, CA. | Vorstandsvorsitzender | - |
Savacor, Inc.
Savacor, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Savacor, Inc. develops implantable medical devices for chronic congestive heart failure (CHF). The company is based in Los Angeles, CA. The company was founded by Frank Litvack. Savacor was acquired by St. Jude Medical LLC, part of Abbott Laboratories from January 05, 2017 on January 03, 2006 for $50 million. | Vorsitzender | 01.01.2005 |
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center Hospital/Nursing ManagementHealth Services Cedars-Sinai Medical Center operates a hospital that provides healthcare services. It specializes in cancer, endocrinology, gynecology, neurology, orthopedics, and respiratory disorders. The company was founded in 1902 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | 01.01.2000 |
Progressive Angioplasty Systems, Inc.
Progressive Angioplasty Systems, Inc. Medical SpecialtiesHealth Technology Part of Medtronic Plc, Progressive Angioplasty Systems, Inc. is a company that makes and develops stents and stent technologies. The company is based in Menlo Park, CA. The company was founded by Frank Litvak, Frank Litvack. Progressive Angioplasty Systems was acquired by United States Surgical Corp. on September 23, 1997 for $150 million. | Gründer | 01.01.1997 |
Genalyte, Inc.
Genalyte, Inc. Medical SpecialtiesHealth Technology Genalyte, Inc. specializes in instrumentation and multiplex assays for biomarker and protein detection. The firm offers autoantibody testing assays for autoimmune research, custom assay services and maverick detection system. The company was founded in 2007 by Lawrence Cary Gunn III and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | - |
Ausbildung von Frank Litvak
McGill University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 6 |
---|---|
Genalyte, Inc.
Genalyte, Inc. Medical SpecialtiesHealth Technology Genalyte, Inc. specializes in instrumentation and multiplex assays for biomarker and protein detection. The firm offers autoantibody testing assays for autoimmune research, custom assay services and maverick detection system. The company was founded in 2007 by Lawrence Cary Gunn III and is headquartered in San Diego, CA. | Health Technology |
Calmedica LLC | |
Conor Medsystems LLC
Conor Medsystems LLC Medical SpecialtiesHealth Technology Conor Medsystems LLC develops vascular drug delivery technologies. Its products include controlled vascular drug delivery technologies and novel stent that are used in the treatment of coronary artery disease and delivery of a broad spectrum of therapeutic agents. The company was founded by John F. Shanley in 1999 and is headquartered in Menlo Park, CA. | Health Technology |
Savacor, Inc.
Savacor, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Savacor, Inc. develops implantable medical devices for chronic congestive heart failure (CHF). The company is based in Los Angeles, CA. The company was founded by Frank Litvack. Savacor was acquired by St. Jude Medical LLC, part of Abbott Laboratories from January 05, 2017 on January 03, 2006 for $50 million. | Health Technology |
Progressive Angioplasty Systems, Inc.
Progressive Angioplasty Systems, Inc. Medical SpecialtiesHealth Technology Part of Medtronic Plc, Progressive Angioplasty Systems, Inc. is a company that makes and develops stents and stent technologies. The company is based in Menlo Park, CA. The company was founded by Frank Litvak, Frank Litvack. Progressive Angioplasty Systems was acquired by United States Surgical Corp. on September 23, 1997 for $150 million. | Health Technology |
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center Hospital/Nursing ManagementHealth Services Cedars-Sinai Medical Center operates a hospital that provides healthcare services. It specializes in cancer, endocrinology, gynecology, neurology, orthopedics, and respiratory disorders. The company was founded in 1902 and is headquartered in Los Angeles, CA. | Health Services |